Lumonus
PrivateLast Round
Series B
Nov 7, 2025
Total Funding Raised
$19.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Lumonus is a healthcare technology company that provides an AI-powered digital oncology platform to automate and orchestrate critical workflows in radiation oncology.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Workflow Automation, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lumonus Comparables
Compare Lumonus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TheraPanacea | 85% | |
| Radformation | 84% | |
| MVision AI | 84% |
Lumonus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 7, 2025 |
Key People
Founding team and executive leadership
Lumonus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aviron Investment Management | Series B |
| Oncology Ventures | Series B |
| Investible | Series B |
| Brandon Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2026
Partnering with Memorial Sloan Kettering Cancer Center to advance radiation oncology.
- Nov 6, 2025
$16M round completed.
Lumonus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Lumonus's valuation, stock price, and market status.
Is Lumonus a public or private company?
Lumonus is a private company.
What is the current stock price of Lumonus?
Lumonus is a private company with no public stock price. No recent secondary market data is available.
How much is Lumonus worth (valuation)?
Valuation information for Lumonus is not publicly available.
Can I buy Lumonus stock?
Lumonus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Lumonus's last funding round?
Lumonus's most recent funding round was Series B on November 6, 2025.
Who are the main investors in Lumonus?
Key investors in Lumonus include Aviron Investment Management.
Will Lumonus IPO soon?
No public IPO plans have been announced for Lumonus.
How can I track Lumonus secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lumonus's secondary market activity and sign up for updates.